Baker Biotech Capital (GP), LLC Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital (GP), LLC. Baker Biotech Capital (GP), LLC is 10% Owner in PHARMACYCLICS INC ($PCYC) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in Ocera Therapeutics, Inc. ($TZYM).
Latest Insider Trading Transactions of Baker Biotech Capital (GP), LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, GHDX, TZYM, PCYC, SGEN, GEVA, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 3.01 | 4,592 | 13,801 | 232,011 | 227.4 K to 232 K (+2.02 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.99 | 7,484 | 22,370 | 227,419 | 219.9 K to 227.4 K (+3.40 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.96 | 15,599 | 46,143 | 219,935 | 204.3 K to 219.9 K (+7.63 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.55 | 56,187 | 143,277 | 204,336 | 148.1 K to 204.3 K (+37.93 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 2.34 | 32,155 | 75,230 | 148,149 | 116 K to 148.1 K (+27.72 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 1.87 | 4,363 | 8,159 | 115,994 | 111.6 K to 116 K (+3.91 %) |
| Mar 14 2012 | TZYM | Ocera Therapeutics ... | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 1.89 | 1,601 | 3,019 | 111,631 | 110 K to 111.6 K (+1.46 %) |
| Jan 09 2012 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 25.18 | 187,576 | 4,723,164 | 1,736,065 | 1.5 M to 1.7 M (+12.11 %) |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Option Exercise | X | 6.25 | 339,788 | 2,123,675 | 0 | |
| Jan 04 2012 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital (GP), LL ... | Director | Buy | X | 6.25 | 339,788 | 2,123,675 | 4,966,001 | 4.6 M to 5 M (+7.34 %) |
| Feb 14 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 20.85 | 150,000 | 3,128,040 | 557,211 | 407.2 K to 557.2 K (+36.84 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.89 | 12,907 | 230,942 | 407,211 | 394.3 K to 407.2 K (+3.27 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.95 | 28,966 | 519,960 | 394,304 | 365.3 K to 394.3 K (+7.93 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.43 | 3,018 | 55,629 | 365,338 | 362.3 K to 365.3 K (+0.83 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.55 | 18,547 | 343,997 | 362,320 | 343.8 K to 362.3 K (+5.40 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.01 | 14,629 | 263,424 | 343,773 | 329.1 K to 343.8 K (+4.44 %) |
| Jan 26 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.86 | 7,926 | 141,534 | 329,144 | 321.2 K to 329.1 K (+2.47 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | X | 15.00 | 16 | 240 | 0 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | X | 15.00 | 28 | 420 | 16 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | P | 15.00 | 16 | 240 | 44 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Option Exercise | P | 15.00 | 28 | 420 | 28 | |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.84 | 7,925 | 133,456 | 321,218 | 313.3 K to 321.2 K (+2.53 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.88 | 12,694 | 214,254 | 313,293 | 300.6 K to 313.3 K (+4.22 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.90 | 7,590 | 128,252 | 300,599 | 293 K to 300.6 K (+2.59 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | X | 15.00 | 1,600 | 24,000 | 293,009 | 291.4 K to 293 K (+0.55 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | X | 15.00 | 2,800 | 42,000 | 291,409 | 288.6 K to 291.4 K (+0.97 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.44 | 12,041 | 197,940 | 288,609 | 276.6 K to 288.6 K (+4.35 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.41 | 31,115 | 510,585 | 276,568 | 245.5 K to 276.6 K (+12.68 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 15.81 | 426 | 6,735 | 245,453 | 245 K to 245.5 K (+0.17 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.07 | 1,795 | 28,843 | 245,027 | 243.2 K to 245 K (+0.74 %) |
| Jan 23 2012 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.07 | 3,839 | 61,686 | 243,232 | 239.4 K to 243.2 K (+1.60 %) |
| Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 30.36 | 2,162 | 65,647 | 1,484,977 | 1.5 M to 1.5 M (+0.15 %) |
| Mar 09 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.88 | 2,346 | 70,097 | 1,482,815 | 1.5 M to 1.5 M (+0.16 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 30.07 | 8,372 | 251,736 | 1,480,469 | 1.5 M to 1.5 M (+0.57 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.96 | 10,225 | 306,301 | 1,472,097 | 1.5 M to 1.5 M (+0.70 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.52 | 10,972 | 323,899 | 1,461,872 | 1.5 M to 1.5 M (+0.76 %) |
| Mar 05 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.47 | 1,763 | 51,956 | 1,450,900 | 1.4 M to 1.5 M (+0.12 %) |
| Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.06 | 19,552 | 568,144 | 1,449,137 | 1.4 M to 1.4 M (+1.37 %) |
| Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.11 | 5,934 | 172,730 | 1,429,585 | 1.4 M to 1.4 M (+0.42 %) |
| Feb 29 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.03 | 4,270 | 123,961 | 1,423,651 | 1.4 M to 1.4 M (+0.30 %) |
| Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.12 | 7,477 | 210,282 | 1,419,381 | 1.4 M to 1.4 M (+0.53 %) |
| Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.98 | 638 | 17,852 | 1,411,904 | 1.4 M to 1.4 M (+0.05 %) |
| Feb 23 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.98 | 5,217 | 145,955 | 1,411,266 | 1.4 M to 1.4 M (+0.37 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.85 | 10,838 | 323,566 | 1,406,049 | 1.4 M to 1.4 M (+0.78 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 29.61 | 11,021 | 326,338 | 1,395,211 | 1.4 M to 1.4 M (+0.80 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.96 | 41 | 1,187 | 1,384,190 | 1.4 M to 1.4 M (0.00 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.88 | 3,944 | 113,892 | 1,384,149 | 1.4 M to 1.4 M (+0.29 %) |
| Feb 16 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.44 | 7,341 | 208,756 | 1,380,205 | 1.4 M to 1.4 M (+0.53 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.52 | 4,378 | 116,089 | 1,372,864 | 1.4 M to 1.4 M (+0.32 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.62 | 2,865 | 76,272 | 1,368,486 | 1.4 M to 1.4 M (+0.21 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.60 | 17,339 | 461,275 | 1,365,621 | 1.3 M to 1.4 M (+1.29 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.24 | 615 | 16,135 | 1,348,282 | 1.3 M to 1.3 M (+0.05 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.33 | 7,858 | 206,873 | 1,347,667 | 1.3 M to 1.3 M (+0.59 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.27 | 387 | 10,166 | 1,339,809 | 1.3 M to 1.3 M (+0.03 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.26 | 9,891 | 259,692 | 1,339,422 | 1.3 M to 1.3 M (+0.74 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.18 | 22,251 | 582,436 | 1,329,531 | 1.3 M to 1.3 M (+1.70 %) |
| Feb 10 2012 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.17 | 999 | 26,139 | 1,307,280 | 1.3 M to 1.3 M (+0.08 %) |
| Jan 03 2012 | ADLR | ADOLOR CORP | Baker Biotech Capital (GP), LL ... | 10% Owner | Sell | U | 4.25 | 79,054 | 335,980 | 0 | 79.1 K to 0 (-100.00 %) |
| Dec 16 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 27.29 | 50,566 | 1,379,860 | 1,966,090 | 1.9 M to 2 M (+2.64 %) |
| Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.18 | 16,278 | 295,985 | 1,915,524 | 1.9 M to 1.9 M (+0.86 %) |
| Oct 06 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.48 | 2,511 | 43,883 | 1,899,246 | 1.9 M to 1.9 M (+0.13 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.08 | 13,576 | 245,450 | 1,896,735 | 1.9 M to 1.9 M (+0.72 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.19 | 6,634 | 120,690 | 1,883,159 | 1.9 M to 1.9 M (+0.35 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.00 | 21,117 | 380,089 | 1,876,525 | 1.9 M to 1.9 M (+1.14 %) |
| Oct 03 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.97 | 11,878 | 213,399 | 1,855,408 | 1.8 M to 1.9 M (+0.64 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 0.00 | 1,046,755 | 0 | 1,548,489 | 501.7 K to 1.5 M (+208.63 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 0.00 | 127,527 | 0 | 501,734 | 374.2 K to 501.7 K (+34.08 %) |
| Nov 04 2011 | GEVA | SYNAGEVA BIOPHARMA ... | Baker Biotech Capital (GP), LL ... | Director | Grant | A | 0.00 | 123,591 | 0 | 374,207 | 250.6 K to 374.2 K (+49.31 %) |
| Dec 06 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 15.42 | 11,694 | 180,358 | 239,393 | 227.7 K to 239.4 K (+5.14 %) |
| Dec 06 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 15.39 | 2,867 | 44,110 | 227,699 | 224.8 K to 227.7 K (+1.28 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 14.92 | 11,164 | 166,590 | 224,832 | 213.7 K to 224.8 K (+5.22 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 14.26 | 11,544 | 164,598 | 213,668 | 202.1 K to 213.7 K (+5.71 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 14.12 | 16,327 | 230,500 | 202,124 | 185.8 K to 202.1 K (+8.79 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.38 | 8,858 | 118,506 | 185,797 | 176.9 K to 185.8 K (+5.01 %) |
| Nov 30 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 13.32 | 16,906 | 225,196 | 176,939 | 160 K to 176.9 K (+10.56 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.76 | 3,141 | 40,079 | 160,033 | 156.9 K to 160 K (+2.00 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.87 | 2,138 | 27,508 | 156,892 | 154.8 K to 156.9 K (+1.38 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.51 | 642 | 8,030 | 154,754 | 154.1 K to 154.8 K (+0.42 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.01 | 1,103 | 13,252 | 154,112 | 153 K to 154.1 K (+0.72 %) |
| Nov 23 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 12.25 | 327 | 4,007 | 153,009 | 152.7 K to 153 K (+0.21 %) |
| Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.62 | 60,000 | 696,960 | 152,682 | 92.7 K to 152.7 K (+64.74 %) |
| Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.54 | 25,000 | 288,553 | 92,682 | 67.7 K to 92.7 K (+36.94 %) |
| Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.79 | 12,317 | 145,184 | 67,682 | 55.4 K to 67.7 K (+22.25 %) |
| Oct 04 2011 | PCYC | PHARMACYCLICS INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 11.79 | 13,846 | 163,236 | 55,365 | 41.5 K to 55.4 K (+33.35 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.39 | 1,385 | 39,320 | 1,306,281 | 1.3 M to 1.3 M (+0.11 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.50 | 1,992 | 56,772 | 1,304,896 | 1.3 M to 1.3 M (+0.15 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.06 | 12,123 | 340,128 | 1,302,904 | 1.3 M to 1.3 M (+0.94 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 28.03 | 3,940 | 110,458 | 1,290,781 | 1.3 M to 1.3 M (+0.31 %) |
| Dec 05 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.33 | 26,537 | 725,256 | 1,286,841 | 1.3 M to 1.3 M (+2.11 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.88 | 1,618 | 41,874 | 1,260,304 | 1.3 M to 1.3 M (+0.13 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.71 | 655 | 16,841 | 1,258,686 | 1.3 M to 1.3 M (+0.05 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.03 | 1,628 | 42,377 | 1,258,031 | 1.3 M to 1.3 M (+0.13 %) |
| Nov 23 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 25.91 | 1,630 | 42,225 | 1,256,403 | 1.3 M to 1.3 M (+0.13 %) |
| Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.50 | 185 | 5,087 | 1,254,773 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 17 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 27.24 | 273 | 7,437 | 1,254,588 | 1.3 M to 1.3 M (+0.02 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.66 | 58 | 1,546 | 1,254,315 | 1.3 M to 1.3 M (0.00 %) |
| Nov 14 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 26.80 | 484 | 12,973 | 1,254,257 | 1.3 M to 1.3 M (+0.04 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 24.49 | 115 | 2,816 | 1,253,773 | 1.3 M to 1.3 M (+0.01 %) |
| Nov 07 2011 | GHDX | GENOMIC HEALTH INC | Baker Biotech Capital (GP), LL ... | Director | Buy | P | 24.42 | 5 | 122 | 1,253,658 | 1.3 M to 1.3 M (0.00 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.13 | 4,697 | 85,155 | 1,843,530 | 1.8 M to 1.8 M (+0.26 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 18.13 | 22,084 | 400,295 | 1,838,833 | 1.8 M to 1.8 M (+1.22 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.78 | 8,828 | 156,988 | 1,816,749 | 1.8 M to 1.8 M (+0.49 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.74 | 25,753 | 456,750 | 1,807,921 | 1.8 M to 1.8 M (+1.45 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.58 | 2,147 | 37,753 | 1,782,168 | 1.8 M to 1.8 M (+0.12 %) |
| Sep 26 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 17.43 | 9,340 | 162,759 | 1,780,021 | 1.8 M to 1.8 M (+0.53 %) |
| Aug 25 2011 | VPHM | VIROPHARMA INC | Baker Biotech Capital (GP), LL ... | 10% Owner | Buy | P | 16.97 | 5,468 | 92,814 | 1,770,681 | 1.8 M to 1.8 M (+0.31 %) |
Page: 1